There is not yet a consensus on the reliability of the methods that should be used for the detection of rare disseminated tumor cells from non-hematological malignancies. In this review, we will discuss the advantage and drawbacks of the classical approach of immunocytochemistry and the molecular detection by reverse transcriptase polymerase chain reaction (RT-PCR). The interpretation of the biological significance of circulating tumor cells and the pitfalls of the detection techniques are the main causes of discrepancy between the conclusions of different tumor-cell detection (TCD) studies.
CITATION STYLE
Goeminne, J. C., Guillaume, T., & Symann, M. (2000). Pitfalls in the detection of disseminated non-hematological tumor cells. Annals of Oncology. https://doi.org/10.1023/A:1008398228018
Mendeley helps you to discover research relevant for your work.